Improvements In Survival And Clinical Benefit With Gemcitabine As First-Line Therapy For Patients With Advanced Pancreas Cancer: A Randomized Trial.

·1997·DOI

Role in the Field

Abstract

Citations

5,456

Year

1997

PageRank

5.1 / 10

Relative influence (log-scaled)

Improvements In Survival And Clinical Benefit With Gemcitabine As First-Line Therapy For Patients With Advanced Pancreas Cancer: A Randomized Trial. | Manumap